Department of Gastroenterological Surgery, Saitama Medical University International Medical Center, 1397-1 Yamane, Hidaka-shi, Saitama, 350-1298, Japan.
Esophagus. 2021 Apr;18(2):187-194. doi: 10.1007/s10388-020-00763-4. Epub 2020 Jul 30.
In esophageal cancer, long-term outcomes of minimally invasive surgery using endoscopic surgery are currently being verified. However, most trials have compared thoracic procedures; few studies have focused on the abdominal procedures, which are important for lymph node dissection in radical esophageal cancer surgery. Hand-assisted laparoscopic surgery (HALS) is a simple and minimally invasive procedure. Although HALS superiority in short-term outcomes has been reported, its oncological safety in esophageal cancer remains unclear. Therefore, we retrospectively evaluated oncological safety of HALS compared with that of conventional open laparotomy (OL) in radical surgery for thoracic and abdominal esophageal cancer.
We retrospectively analyzed the postoperative survival in 142 patients who underwent radical esophageal cancer surgery at our hospital between May 2012 and May 2017, with and without propensity score matching (PSM) between groups.
Before PSM, OL (n = 65) and HALS (n = 77) groups differed significantly in overall survival (OS) (3-year OS rate: 74.2% and 87.3%, respectively; log-rank p = 0.040). Additionally, clinical abdominal lymph node metastasis (cALNM) independently predicted OS (p = 0.031). After PSM, the OL and HALS groups did not differ significantly in OS (3-year OS rate: 80.5% and 89.8%, respectively; log-rank p = 0.716). There was no statistically significant difference in abdominal-specific recurrence-free survival between the OL and HALS group before and after PSM.
HALS may be a well-accepted procedure for radical esophagectomy in esophageal cancer, with oncological safety, including local control specific to the abdomen, comparable to that of the conventional OL.
在食管癌中,微创内镜手术的长期疗效正在得到验证。然而,大多数试验都比较了胸段手术;很少有研究关注根治性食管癌手术中重要的腹部手术,即腹腔镜辅助手术(HALS)。HALS 是一种简单微创的手术。虽然 HALS 在短期疗效方面的优势已被报道,但在食管癌中的肿瘤安全性仍不清楚。因此,我们回顾性评估了 HALS 与传统开腹手术(OL)在胸腹部食管癌根治性手术中的肿瘤安全性。
我们回顾性分析了我院 2012 年 5 月至 2017 年 5 月期间接受根治性食管癌手术的 142 例患者的术后生存情况,对两组患者进行了倾向评分匹配(PSM)。
在 PSM 之前,OL(n=65)和 HALS(n=77)组在总生存(OS)方面存在显著差异(3 年 OS 率:分别为 74.2%和 87.3%;log-rank p=0.040)。此外,临床腹部淋巴结转移(cALNM)独立预测 OS(p=0.031)。PSM 后,OL 和 HALS 组在 OS 方面无显著差异(3 年 OS 率:分别为 80.5%和 89.8%;log-rank p=0.716)。PSM 前后,OL 和 HALS 组的腹部特异性无复发生存率无统计学差异。
HALS 可能是食管癌根治性手术中一种可接受的方法,其肿瘤安全性,包括腹部局部控制,与传统 OL 相当。